As filed with the Securities and
Exchange Commission on March 27, 2020
Registration
No. 333-66566
______
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
POST
EFFECTIVE AMENDMENT NO. 1 TO
FORM
S-8
REGISTRATION
STATEMENT UNDER
THE SECURITIES ACT OF
1933
MICRON
SOLUTIONS, INC.
(Exact name of
registrant as specified in its charter)
Delaware
(State or other
jurisdiction of
incorporation of
organization)
|
72-0925679
(I.R.S. Employer
Identification No.)
|
25
Sawyer Passway, Fitchburg, MA 01420
|
(Address of Principal
Executive Offices)
1987
INCENTIVE STOCK OPTION PLAN
MICRON EMPLOYEE
STOCK OWNERSHIP PLAN
1994
STOCK OPTION PLAN FOR DIRECTORS
(Full
titles of the plans)
William J.
Laursen
President
Micron
Solutions, Inc.
25
Sawyer Passway, Fitchburg, MA 01420
(Name and address of
agent for service)
(978
345-5000)
(Telephone number,
including area code, of agent for service)
Indicate by check
mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of “large accelerated
filer”, “accelerated filer”, and “smaller reporting company” in
Rule 12b-2 of the Exchange Act.
Large accelerated
filer□Accelerated Filer □
Non-accelerated
filer■Smaller reporting company
■
Emerging growth
company □
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised □
DEREGISTRATION OF
UNSOLD SECURITIES
This
Post-Effective
Amendment No. 1 to the Registration Statement on Form S-8 is
being filed in order to deregister all securities remaining unsold
under that certain Registration Statement on Form S-8 (Registration
No. 333-66566)
which was filed on August
2, 2001 (the
“Registration
Statement”) to
register 38,500
shares
of the common stock of Micron Solutions, Inc. (known
at such time as Arrhythmia
Research Technology, Inc.)
(the
“Company”)
issuable under the Arrhythmia Research Technology, Inc.
1987
Incentive Stock Option Plan,
90,000 shares of the common stock of the Company issuable under
the Arrhythmia
Research Technology, Inc. 1994
Stock Option Plan
for
Directors, and 52,591 shares of the common stock of the Company
issuable under the Micron Employee Stock Ownership
Plan.
The
Registration Statement is hereby amended to remove from
registration the securities registered but unsold under the
Registration Statement.
On
March 26, 2020, the Company filed a
Form
25 to delist the Company’s shares of common stock on the NYSE
American. The Company intends to file Form 15 to terminate
registration under Section 12(g) of the Securities Exchange
Act of 1934, as amended (the “Exchange
Act”),
and its duty to file reports under Section 15(d) of the Exchange
Act.
SIGNATURES
Pursuant to the
requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets
all the requirements for filing on Form S-8 and has duly caused
this Registration Statement on Form S-8 to be signed on its behalf
by the undersigned, thereunto duly authorized, in the town
of Fitchburg, Commonwealth of Massachusetts
on March 27, 2020.
MICRON
SOLUTIONS, INC.
By:
/s/
William
J. Laursen _
William
J. Laursen
President